Telomerase Protein Extends Cell Lifespan Without Lengthening Telomeres
New research reveals hTERT can prevent cellular aging through telomere compaction rather than lengthening, challenging current understanding.
Summary
Researchers discovered that the telomerase protein hTERT can extend cellular lifespan without actually lengthening telomeres. Using human fibroblasts, they found that mutant hTERT variants unable to maintain telomere length still prevented cellular senescence by increasing TRF2 protein levels and compacting telomeres. This compaction blocked DNA damage signaling that normally triggers aging, allowing cells to continue dividing despite having shorter telomeres than senescent cells. The findings challenge the prevailing view that telomere length alone determines cellular aging and suggest cancer cells may achieve immortality through telomere compaction rather than lengthening.
Detailed Summary
This groundbreaking study challenges the fundamental understanding of how telomeres regulate cellular aging. Researchers at the University of Calgary investigated whether telomerase reverse transcriptase (hTERT) extends cell lifespan solely through telomere lengthening or through alternative mechanisms.
The team studied three primary human fibroblast strains and introduced wild-type hTERT along with two disease-associated mutants (V144M and R865C) found in pulmonary fibrosis patients. Remarkably, cells expressing mutant hTERT continued dividing for 79 mean population doublings despite having telomeres shorter than senescent control cells (2.93-2.35 kb vs 4.11-4.13 kb for chromosome 17p). These mutant-expressing cells showed 53BP1 DNA damage foci levels similar to young cells (2-3 foci/cell) rather than senescent cells (9-10 foci/cell).
Using super-resolution microscopy, researchers discovered that hTERT variants induced telomere compaction, creating denser chromatin structures. This occurred through upregulation of TRF2, a key shelterin protein, via decreased Siah1 E3 ubiquitin ligase levels and increased CDC20 and FBXO5 ligase expression. The restored TRF2:TRF1 ratio blocked ATM kinase activation and subsequent p53-mediated senescence signaling.
The findings suggest cancer cells may achieve immortality not by maintaining long telomeres, but by stabilizing shelterin components to maintain telomere density and block DNA damage responses. This represents a paradigm shift from the length-centric model of telomere biology to a structure-function relationship where telomere compaction, independent of length, determines cellular fate. The research opens new therapeutic avenues for age-related diseases and cancer treatment strategies targeting telomere structure rather than length.
Key Findings
- Mutant hTERT-expressing cells continued dividing for 79 population doublings with telomeres 29-43% shorter than senescent controls
- DNA damage foci decreased from 9-10 per senescent cell to 2-3 per cell in hTERT mutant-expressing fibroblasts
- TRF2 protein levels increased 2-3 fold in cells expressing hTERT variants compared to senescent controls
- Telomere compaction increased significantly in hTERT-expressing cells as measured by super-resolution microscopy
- Siah1 E3 ubiquitin ligase levels decreased while CDC20 and FBXO5 ligase levels increased in hTERT-expressing cells
- All three fibroblast strains lost 40-55 bp of telomeric DNA per telomere per cell division during normal aging
- Wild-type hTERT increased average telomere length 3-fold while mutants showed no length maintenance
Methodology
The study used three primary human fibroblast strains (WI38, Hs68, BJ) stably transfected with wild-type or mutant hTERT. Telomere length was measured using telo-qPCR, terminal restriction fragment assays, and single telomere length analysis (STELA). DNA damage was assessed through immunofluorescence for 53BP1 and γH2AX foci. Super-resolution microscopy quantified telomere compaction, while protein expression was analyzed via Western blotting and qRT-PCR across multiple biological replicates.
Study Limitations
The study was conducted exclusively in cultured human fibroblasts, limiting generalizability to other cell types and in vivo conditions. The research focused on specific hTERT mutants associated with pulmonary fibrosis, so findings may not apply to all telomerase variants. Long-term effects of telomere compaction without length maintenance remain unclear, and the study did not examine potential negative consequences of sustained proliferation with short telomeres.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.